ACTRIMS Forum 2021: Serum Neurofilament Light Chain Shows Promise as a Real-World Clinical Marker for Multiple Sclerosis
Higher levels linked with disease duration, neurological symptoms, and brain atrophy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.